Please check your internet connection and try again.
# Feza
## Overview
- **Classification**: Selective Serotonin Reuptake Inhibitor (SSRI)
- **Mechanism**: Potently inhibits serotonin reuptake in the neuronal synapse, leading to increased serotonin availability.
## Primary Indications
1. **Major Depressive Disorder (MDD)** - Treatment of depressive episodes
2. **Generalized Anxiety Disorder (GAD)** - Management of chronic anxiety
3. **Panic Disorder** - Reduction of panic attack frequency and severity
## Adult Dosing
### Standard Dosing
**Major Depressive Disorder (MDD)**
- **Dose**: **20 mg**
- **Frequency**: Once daily
- **Route**: Oral
- **Duration**: Typically long-term, reassess after 6-12 months
**Generalized Anxiety Disorder (GAD)**
- **Dose**: Start **10 mg** once daily for 1 week, then increase to **20 mg**
- **Frequency**: Once daily
- **Route**: Oral
### Dose Adjustments
- **Renal Impairment**:
- CrCl 30-60 mL/min: No adjustment needed.
- CrCl <30 mL/min: Consider lower starting dose (**10 mg**) and titrate cautiously.
- **Hepatic Impairment**:
- Mild-Moderate: Start **10 mg** once daily. Max **20 mg**/day.
- Severe: Not recommended.
- **Elderly Patients**: Start with lower dose (**10 mg** once daily) due to decreased clearance and increased sensitivity. Max **40 mg**/day.
## Pediatric Dosing
### Neonates (0-28 days)
- **Dose**: Not recommended.
- **Special Notes**: Safety and efficacy not established. Potential for persistent pulmonary hypertension of the newborn (PPHN) if maternal use in late pregnancy.
### Infants (1-12 months)
- **Dose**: Not recommended.
- **Special Notes**: Safety and efficacy not established. Alternative treatments should be considered.
### Children (1-12 years)
**Major Depressive Disorder / Generalized Anxiety Disorder** (Off-label/Specialist use)
- **Dose**: Start **5 mg** once daily for 1 week, then increase to **10 mg** once daily.
- **Frequency**: Once daily
- **Maximum**: **20 mg**/day
- **Special Notes**: Closely monitor for suicidal ideation, especially during initiation.
### Adolescents (13-18 years)
**Major Depressive Disorder / Generalized Anxiety Disorder**
- **Dose**: Start **10 mg** once daily for 1-2 weeks, then increase to **20 mg** once daily.
- **Frequency**: Once daily
- **Maximum**: **40 mg**/day
- **Special Notes**: Monitor closely for worsening depression and suicidality.
## Safety Information
### Contraindications
- **Absolute**: Concomitant use with MAO inhibitors (MAOIs) or within 14 days of discontinuing an MAOI.
- **Absolute**: Hypersensitivity to Feza or any component.
- **Relative**: Concomitant use with pimozide or thioridazine (QT prolongation risk).
### Common Adverse Effects
- **Very Common (>10%)**: Nausea, insomnia, somnolence, headache, diarrhea.
- **Common (1-10%)**: Dry mouth, sweating, dizziness, sexual dysfunction, tremor.
- **Serious but Rare**: Serotonin syndrome, suicidal ideation, QT prolongation, hyponatremia.
### Key Drug Interactions
- **MAO Inhibitors**: Risk of **serotonin syndrome**. Contraindicated.
- **Tricyclic Antidepressants (TCAs)**: Increased TCA plasma levels. Monitor for toxicity.
- **NSAIDs/Anticoagulants**: Increased bleeding risk. Use with caution.
- **QT-prolonging drugs**: Increased risk of Torsades de Pointes. Avoid co-administration.
## Monitoring & Follow-up
- **Before Treatment**: Baseline weight, height (peds), suicidal ideation assessment. ECG if cardiac risk factors present.
- **During Treatment**:
- **Weekly for first 4 weeks**: Monitor for suicidality, anxiety, agitation.
- **Bi-weekly for next 4 weeks**: Continue symptom and adverse effect monitoring.
- **Periodically thereafter**: As clinically indicated.
- **Electrolytes**: Monitor sodium, especially in elderly or those on diuretics.
- **Clinical Signs**: Watch for agitation, hallucinations, rapid heart rate, fever (serotonin syndrome).
## Clinical Pearls
- 💡 **Tip 1**: Administer Feza in the morning to minimize insomnia if activating. If sedating, consider evening dose.
- 💡 **Tip 2**: Taper dose slowly over several weeks when discontinuing to avoid withdrawal symptoms (e.g., dizziness, paresthesias).
- 💡 **Tip 3**: Counsel patients that full therapeutic effects may take 2-4 weeks to become apparent.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.